The Junior Investigator Global ATTR Amyloidosis Research ASPIRE from Pfizer supports early-career principal investigators worldwide (except for the USA) working on ATTR Amyloidosis. The grant seeks to fund projects on:
- Epidemiologic evaluations for ATTR amyloidosis
- Approaches for the early identification and follow up of ATTR amyloidosis patients
- RW efficacy and safety of tafamidis in the clinical setting for the management of ATTR amyloidosis
- Evaluation of patients with ATTR-CM presenting with a mixed phenotype (e.g. cardiomyopathy and polyneuropathy)
The applicant must be affiliated with a research institution outside of the USA and have obtained their terminal degree within the past 10 years. Applicants may apply for up to 75,000 USD/year in funding support (including up to 28% of overheads) for 1-2 years.
Applications close on March 21, 2023.
March 21, 2023